Calithera Biosciences Priced, Nasdaq: CALA

Early-stage biotech developing a drug platform that inhibits tumor metabolism.

Industry: Health Care

Latest Trade: $11.58 +0.33 (+2.9%)

First Day Return: -5.9%

Return from IPO: +12.5%

Industry: Health Care

Early-stage biotech developing a drug platform that inhibits tumor metabolism.
more less
IPO News for Calithera Biosciences
more
IPO Data
IPO File Date 08/25/2014
Offer Price $10.00
Price Range $13.00 - $15.00
Offer Shares (mm) 8.0
Deal Size ($mm) $80
IPO Data
IPO Date 10/01/2014
Offer Price $10.00
Price Range $13.00 - $15.00
Offer Shares (mm) 8.0
Deal Size ($mm) $80
Underwriters
more
Company Data
Headquarters South San Francisco, CA
Founded 2010
Employees 36
Website www.calithera.com